John, I put another call into CMS to see about supplying test files to the WEDI SNIP repository. They are forwarding my request to Central Office in Baltimore. I am also asking about test data on our private side.
I am starting to review the B2B terms per the minutes and will try to email you any comments I have tonight. Just a note, I think I volunteered with Ed Hafner to assist in updating the B2B paper although the minutes don't reflect that. While I won't be there tomorrow I can get w/Ed later to work on any revision requests. You don't have to ask for volunteers. Good luck! ----- Original Message ----- From: <[EMAIL PROTECTED]> To: "WEDI SNIP Testing Subworkgroup List" <[EMAIL PROTECTED]> Sent: Wednesday, October 30, 2002 12:06 PM Subject: Meeting Reminder and Agenda - 10/31/2002 > Happy Halloween everyone, > > Just a reminder that we have a Testing SWG conference call tomorrow at 11 > a.m. eastern time. The call in number is 703-736-7290 pc 1315339#. The > agenda for the meeting is as follows: > > * Roll Call and Volunteers for Minutes, Timekeeper > * Phoenix Summit (10 minutes) > - Bios > - Presentation to Kristin > - Permission to Record Forms > > * Test Scenarios (15 minutes) > - Web Sites/Validation Reports > - Institutional Technical Scenario Update > > * Business to Business White Paper (30 minutes) > - New Facilitators > - Tie in with Front End Edits Paper > - Survey > > * Miscellaneous (5 minutes) > > > Here are the minutes from our previous meeting: > > Meeting Minutes - 10/17/2003 > > Meeting Facilitator - Sue Ryder > Time Keeper - Dave Frankel > Minutes - John Lilleston > > November WEDI SNIP Summit in Phoenix > > John wanted to remind everyone that presentations are due to Kristin Becker > by 10/25 to be included in the conference handouts. Also, bios are overdue > to Kristin and that each person participating in the panel/presentation > should have received a form to sign to allow the session to be recorded and > put to CD Rom. Please return those forms to the fax number on the form > ASAP. John will send a copy of the form to Ed Hafner who had not received > one. > > Test Scenarios > > Sue stated that the dental test scenarios were delivered to Kepa. Kepa and > Jeff from Claredi said that the finished scenarios should be available in > the next few days on Claredi's web site. Kepa asked if one of the other > testing tool vendors would like to run the files through their tools and > then post the results on the site. Ed Hafner said he would check with his > people. If he is not able to do this, Kepa will run these through his > validator and post the results. There are approximately 2800 dental files > that will be generated. > > John stated that the institutional scenarios are nearly complete. > Scenarios have been completed up through page 396 of the guide. Mark > Charles has been assigned pages 397-439. Brandi Wyatt and Paul Root > volunteered to split the rest of the guide. John will email each of them > with their assigned part. Kepa asked that we ensure that the > instructions he distributed be followed when completing these scenarios. > John will review the spreadsheet to investigate if we have followed the > instructions. > > Sue then gave an update as to her request to CMS to post Medicare business > scenarios on our web sites. She sent an email to her CMS rep but has yet > to get a response. She will keep us posted. > > Business to Business Paper > > Brandi Wyatt will follow up on the email from Rich Maere about the possible > overlap of effort between what we are trying to do with the companion > documents piece of the B2B paper. Once she does that, we should be able to > move forward on our survey on best practices on business to business > testing. We may be able to work together with the other group or use what > they have previously developed. > > Per our previous meeting, we decided to identify some of the terms in the > B2B paper that we need to further define in a "Key Terms" section of the > paper. The group agreed we should define business to business testing, > companion guides (along with implications to companion guides in the final > rule, the "should/should nots" in the implementation guides, and the pros > and cons of using companion guides), application testing, and > partner-specific edits. The group also suggested that we should add a few > paragraphs to the B2B paper to attempt to tie together the Testing and > Certification Paper, the Business to Business Testing Paper, and the Front > End Edits paper. Please review the Business to Business Paper on the SNIP > web site prior to the next meeting and let us know of any other terms you > think need further definition. Also, it was suggested that the group read > the Front End Edits paper in order to incorporate some of those ideas. A > new version of the Front End Edits paper is about to be released and John > Lilleston will request a copy of that paper from Peter Barry. John will > distribute to the group when he receives it. > > Miscellaneous > > The group suggested that we hold a pre-Phoenix conference call with those > members who are presenting or who are on the panel in order to review what > we will discuss. This should help ensure that everyone is comfortable with > their piece of the discussion and that we present a united message to those > in attendance. John will follow up with Mark Charles, Sunny Singh, and Dr. > Kovac to see if October 23rd at 1:30 eastern time is a good time for > everyone. Other times suggested were the 24th and 25th at 1:30 eastern > time. > > We then continued a discussion from the last meeting concerning > interpretations of the implementation guide rules. Kepa stated that Rich > Landon of the BCBS Association is starting up a group to document and > suggest resolutions to these issues. Brandi Wyatt will try to find further > information as to meeting times, etc. and get back with the group. At that > point we will decide what type of interaction that the Testing SWG should > have with this group. > > At one point in the call, someone from the Institute of Medicine asked a > question about the testing scenarios. The group was very glad to have you > on the call and would like to encourage your participation in our > workgroup. We could definitely use your help in defining terms, etc. for > our white papers. Please continue to participate. > > _______________________________________________ > > John Lilleston > Technical Supervisor > Verizon Information Technologies, Inc. > Healthcare Solutions > 813-979-3225 > [EMAIL PROTECTED] > http://www.VerizonIT.com/ > _______________________________________________ > > > > --- > The WEDI SNIP listserv to which you are subscribed is not moderated. The discussions on this listserv therefore represent the views of the individual participants, and do not necessarily represent the views of the WEDI Board of Directors nor WEDI SNIP. If you wish to receive an official opinion, post your question to the WEDI SNIP Issues Database at http://snip.wedi.org/tracking/. These listservs should not be used for commercial marketing purposes or discussion of specific vendor products and services. They also are not intended to be used as a forum for personal disagreements or unprofessional communication at any time. > > You are currently subscribed to wedi-testing as: [EMAIL PROTECTED] > To unsubscribe from this list, go to the Subscribe/Unsubscribe form at http://subscribe.wedi.org or send a blank email to [EMAIL PROTECTED] > If you need to unsubscribe but your current email address is not the same as the address subscribed to the list, please use the Subscribe/Unsubscribe form at http://subscribe.wedi.org > > > "Empire Health Choice Inc." made the following annotations on 10/30/02 14:36:28 ------------------------------------------------------------------------------ [INFO] -- Access Manager: Attention! This electronic message contains information that may be legally confidential and/or privileged. The information is intended solely for the individual or entity named above and access by anyone else is unauthorized. If you are not the intended recipient, any disclosure, copying, distribution, or use of the contents of this information is prohibited and may be unlawful. If you have received this electronic transmission in error, please reply immediately to the sender that you have received the message in error, and delete it. --- The WEDI SNIP listserv to which you are subscribed is not moderated. The discussions on this listserv therefore represent the views of the individual participants, and do not necessarily represent the views of the WEDI Board of Directors nor WEDI SNIP. If you wish to receive an official opinion, post your question to the WEDI SNIP Issues Database at http://snip.wedi.org/tracking/. These listservs should not be used for commercial marketing purposes or discussion of specific vendor products and services. They also are not intended to be used as a forum for personal disagreements or unprofessional communication at any time. You are currently subscribed to wedi-testing as: [email protected] To unsubscribe from this list, go to the Subscribe/Unsubscribe form at http://subscribe.wedi.org or send a blank email to [EMAIL PROTECTED] If you need to unsubscribe but your current email address is not the same as the address subscribed to the list, please use the Subscribe/Unsubscribe form at http://subscribe.wedi.org
